首页> Annals of translational medicine> SULF2 is a novel diagnostic and prognostic marker for high-grade bladder cancer with lymphatic metastasis.

SULF2 is a novel diagnostic and prognostic marker for high-grade bladder cancer with lymphatic metastasis.

导出 LinkOut

翻译打印收藏纠错

第一作者： Jianhua,Huang

第一单位： Department of Urology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.;Institute of Urinary Oncology, School of Medicine, Tongji University, Shanghai, China.

作者： Jianhua,Huang ^[1] ; Cheng,Li ^[1] ; Wentao,Zhang ^[1] ; Fuhan,Yang ^[1] ; Ruiliang,Wang ^[1] ; Junfeng,Zhang ^[1] ; Wei,Li ^[1] ; Xudong,Yao ^[1]

作者单位： Department of Urology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.;Institute of Urinary Oncology, School of Medicine, Tongji University, Shanghai, China. ^[1]

关键词 Sulfatase 2 (SULF2)bladder cancer (BCa)diagnosis lymphatic metastasis prognosis

DOI 10.21037/atm-21-4102

PMID 34733991

发布时间 2022-04-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Annals of translational medicine

2021年9卷18期

1439页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览1

点击下载本期目录封面

Annals of translational medicine

2021年9卷18期

1439页

检索历史清除

SULF2 is a novel diagnostic and prognostic marker for high-grade bladder cancer with lymphatic metastasis.

Annals of translational medicine

相似文献

同项目论文

Annals of translational medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

SULF2 is a novel diagnostic and prognostic marker for high-grade bladder cancer with lymphatic metastasis.

Annals of translational medicine

相似文献

同项目论文

Annals of translational medicine

相关期刊

检索历史清除